Medical Device | January 13, 2022
BioGenex RT-PCR Kit detects all Covid variants in half the time
This test analyses samples in VTM directly without the need for RNA extraction step
This test analyses samples in VTM directly without the need for RNA extraction step
The medicine is the first and only oral MET inhibitor to receive CHMP positive opinion in Europe for adult patients with advanced NSCLC harbouring alterations leading to METex14 skipping
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
Acute therapies continue to report strong growth compared to chronic ones.
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
Subscribe To Our Newsletter & Stay Updated
